NCT07070622View on ClinicalTrials.gov

Planed Organ Preservation for Low Rectal Cancer After Neoadjuvant Chemotherapy (OPLAR)

PHASE3RecruitingINTERVENTIONAL

Enrollment

186

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2029

Conditions

Rectal Cancer

Interventions

DRUG

patients were assigned to receive TNT or iTNT management

TNT or iTNT

Trial Locations (1)

610041

RECRUITING

West China Hospital, Chengdu

All Listed Sponsors

lead

West China Hospital

OTHER